Discontinued — last reported Q4 '23
3M Health Care — D&A remained flat by 0.0% to $149.25M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $155.75M to $149.25M. Over 2 years (FY 2021 to FY 2023), Health Care — D&A shows relatively stable performance with a -3.1% CAGR.
Higher levels relative to revenue suggest a capital-intensive business model or recent significant investment in long-lived assets.
This metric represents the systematic allocation of the cost of tangible and intangible assets over their useful lives w...
Comparable to 'Depreciation and Amortization' reported in segment-level operating performance disclosures.
mmm_segment_health_care_depreciation_and_amortization| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | 636M | 623M | 597M |
| YoY Change | — | -2.0% | -4.2% |